Wednesday, July 8, 2026

pharma · Polycythemia Vera · Ulcerative Colitis Chronic Moderate · PTGX

Protagonist Therapeutics

News and analysis for Protagonist Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

7707 Gateway Blvd, Suite 140, Newark, California 94560, US HQ
2006 Founded
153 Employees
Public company Type
PTGX · NYSE Ticker
Company details
Status
Public
HQ
7707 Gateway Blvd, Suite 140, Newark, California 94560, US
Founded
2006
Employees
153
Programs
13
Drugs
5
Patents
33
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Protagonist Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Protagonist Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Protagonist Therapeutics yet.

Back to company overview →